`Case 2:10—cv—O6108—ES—JAD Document 316 Filed 03/24/14 Page 1 of 2 Page|D: 10556
`
`Charles M. Lizza
`
`William C. Baton
`
`SAUL EWING LLP
`
`One Riverfront Plaza
`
`Newark, New Jersey 07102-5490
`(973) 286-6700
`clizza@saul.com
`
`Attorneys for Plaintiff
`Jazz Pharmaceuticals, Inc.
`
`UNITED STATES DISTRICT COURT
`
`DISTRICT OF NEW JERSEY
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Plaintiff,
`
`v-
`
`ROXANE LABORATORIES, INC.,
`
`Defendant.
`
`
`
`Civil Action No. 10-6108 (ES)(MAH)
`
`, ORDER
`
`(Filed Electronically)
`
`THIS MATTER having come before the Court on the motion of Plaintiff Jazz
`
`Pharmaceuticals, Inc. to Bifurcate Claims Relating to the ’730 Patent Family (D.I. 265)]; and
`
`Defendant Roxane Laboratories, Inc., having opposed the motion; and the Court having
`
`thoroughly considered the moving and opposing papers and oral arguments of counsel; and for
`
`good cause shown;
`
`IT IS on this 4,2_‘-[:7day of
`
`, 2014,
`
`ORDERED that Plaintiff Jazz Pharmaceuticals, Inc.’s motion to Bifurcate Claims
`
`Relating to the ’730 Patent Family is hereby GRANTED; and it is further
`
`I The “’730 Patent Family” refers to U.S. Patent Nos. 7,668,730, 7,765,106, 7,765,107, and 7,895,059.
`
`
`
`AMN1061
`AMN1061
`
`
`
`
`Case 2:10-cv-06108-ES-JAD Document 316 Filed 03/24/14 Page 2 of 2 PageID: 10557
`Case 2:10—cv—O6108—ES—JAD Document 316 Filed 03/24/14 Page 2 of 2 Page|D: 10557
`
`ORDERED that the parties’ claims and defenses relating to the ’730 Patent Family are
`
`hereby BIFURCATED and STAYED.
`
`
`
`AMN1061
`AMN1061